News
The quality of mental health, both at the individual and community level, has become a matter of global concern. According to the World Health Organization (WHO), 15% of working-age adults were estimated to have a mental disorder in 2019. It is also estimated that $1 trillion is lost every year due to depression and anxiety among workers.
Nearly 70 startups, plus hundreds of attendees and media from around the globe convened yesterday for CES Unveiled Amsterdam. The event highlighted tech innovation from European startups that will solve global challenges and conference programming addressing sustainability, healthcare, climate change, and tech trends—including digital health, enterprise, AI, and a look toward using tech for good.
The Consumer Technology Association (CTA) announced that HD Hyundai, the world’s largest shipbuilder, will keynote at CES 2024 to share tech-first strategies which employ technology for building a more sustainable future. HD Hyundai, a global company also known for specialised construction equipment and energy solutions, further excels in developing eco-friendly infrastructure technology, as well as retrofitting carriers and shipyards.
The Consumer Technology Association (CTA) announced Gail K. Boudreaux, president and CEO of Elevance Health, will headline a keynote session to discuss how the company is implementing an innovative whole-health approach to care. It complements the Digital Health Summit, which returns to CES 2024, and will focus on the outlook for health care in the U.S. and beyond.
Upfront Diagnostics, a healthcare company focused on discovering novel biomarkers that can be applied to medical diagnosis, has started the last phase of clinical evaluation of a point-of-care rapid blood test designed to rapidly identify when stroke is caused by a blood clot blocking a main blood vessel within the brain. This is known as large vessel occlusion (LVO).
Finnish biotech startup Enifer has contributed to a new study on farmed salmon that was done in collaboration with the Norwegian University of Life Sciences (NMBU). The study utilised Enifer’s PEKILO®Aqua mycoprotein, and it was conducted by a group of researchers led by Professor Margareth Øverland.













